Pliant Therapeutics Inc (PLRX)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current PLRX market cap is 89.4M. The company's latest EPS is USD -3.4343 and P/E is -0.42.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -47.04M | -52.39M | -60.64M | -62.01M | -53.32M |
| Net Income | -41.11M | -46.96M | -55.85M | -57.76M | -49.73M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 41.82M | 7.57M | 9.69M | 1.58M | 0 |
| Operating Income | -41.65M | -97.54M | -127.2M | -184.15M | -228.37M |
| Net Income | -41.53M | -97.26M | -123.32M | -161.34M | -210.3M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 512.15M | 521.61M | 483.73M | 445.67M | 396.95M |
| Total Liabilities | 38.58M | 84.27M | 91.05M | 99.84M | 92.87M |
| Total Equity | 473.58M | 437.33M | 392.68M | 345.82M | 304.08M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 295.53M | 221.22M | 350.61M | 512.15M | 396.95M |
| Total Liabilities | 12.47M | 22.16M | 37.27M | 38.58M | 92.87M |
| Total Equity | 283.06M | 199.06M | 313.34M | 473.58M | 304.08M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -116.36M | -30.27M | -75.57M | -107.84M | -155.5M |
| Investing | -127.01M | 59.55M | 70.25M | 101.21M | 140.34M |
| Financing | 274.41M | 19.91M | 22.47M | 23.02M | 23.12M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -37.27M | -75.44M | -94.63M | -116.36M | -155.5M |
| Investing | -210.87M | 73.7M | -150.2M | -127.01M | 140.34M |
| Financing | 213.21M | 2.53M | 226.85M | 274.41M | 23.12M |
| Market Cap | 89.4M |
| Price to Earnings Ratio | -0.42 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.25 |
| Price to Book Ratio | 0.29 |
| Dividend Yield | - |
| Shares Outstanding | 61.24M |
| Average Volume (1 week) | 917.98k |
| Average Volume (1 Month) | 1.44M |
| 52 Week Change | -89.01% |
| 52 Week High | 16.52 |
| 52 Week Low | 1.1001 |
| Spread (Intraday) | 0.16 (11.03%) |
| Company Name | Pliant Therapeutics Inc |
| Address |
850 new burton road suite 201 dover, delaware 19904 |
| Website | https://pliantrx.com. |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
